Long-Bin Jeng

10PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursExperimental methods in fluid flow, heat and mass transfer
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 25, 2023
Increased plasma levels of monocyte chemoattractant protein-1 in patients with hepatitis B virus pre-S2 gene deletion mutation predict a higher risk of hepatocellular carcinoma recurrence after curative surgical resection.

Long-Bin Jeng, Tsai-Chung Li, John Wang

|Dec 06, 2021
Correction notice to "Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model".

Chiao-Fang Teng, Ting Wang, Tzu-Hua Wu

|Jan 19, 2021
Therapeutic efficacy of dendritic cell vaccine combined with programmed death 1 inhibitor for hepatocellular carcinoma.

Chiao-Fang Teng, Ting Wang, Fu-Ying Shih

|Jan 14, 2021
Increased infiltration of regulatory T cells in hepatocellular carcinoma of patients with hepatitis B virus pre-S2 mutant.

Chiao-Fang Teng, Tsai-Chung Li, Ting Wang

|Nov 25, 2020
Hepatitis B virus pre-S2 deletion (nucleotide 1 to 54) in plasma predicts recurrence of hepatocellular carcinoma after curative surgical resection.

Chiao-Fang Teng, Tsai-Chung Li, Hsi-Yuan Huang

|Jun 23, 2020
Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model.

Chiao-Fang Teng, Ting Wang, Tzu-Hua Wu

Pageof 2

Frequent Collaborators

2 joint publications

Chiao-Fang Teng

1 joint publications

Tsai-Chung Li

1 joint publications

Cemalettin Koc

1 joint publications

Sami Akbulut